Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Core Scientific, Inc./tx (CORZ)

Core Scientific Q3 revenue rises to $232.9 million; net income $1.18 billion on warrant gain

Positive Impact 3 of 5 earnings Written later

Core Scientific reported third-quarter 2026 results, with total revenue of $232.9 million, up from $164.2 million in the second quarter and $81.1 million a year earlier. Net income was $1.18 billion, mainly from a non-cash gain tied to changes in the fair value of warrants, compared with a net loss of $1.16 billion in the prior quarter. The company says colocation revenue is growing as it delivers capacity under its first colocation agreement, while construction under its second is underway across five campuses.

Key points

  • Total revenue of $232.9 million for the quarter ended September 30, 2026, versus $164.2 million in Q2 2026 and $81.1 million in Q3 2025.
  • Net income of $1.18 billion ($0.47 diluted per share), driven mainly by a $1.03 billion gain from the change in fair value of warrants and contingent value rights.
  • Adjusted EBITDA of $133.6 million, up from $41.1 million in Q2 2026; operating income of $72.4 million versus an operating loss of $78.5 million in Q2 2026.
  • Colocation revenue of $215.4 million with 485 MW billing as of September 30, 2026; liquidity and DSRA of $1.74 billion, down from $2.60 billion at June 30, 2026.

The filing

CompanyCore Scientific, Inc./tx (CORZ)
Form8-K, current report
Filed with the SECNov 5, 2026, 7:04 AM ET
Accession number0001839341-26-000028

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.